百济JPM2025

143RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE 2025January 13-16, 2025 | San Francisco, CaliforniaAn Inflection Point 2Certain statements contained in this presentation and in the accompanying oral presentation, other than statements of fact that are independently verifiable at the date hereof, constitute forward looking statements. Examples of such forward-looking statements include statements regarding the projected size of the oncology market and related sectors; BeiGene’sresearch, discovery, pre-clinical and early-stage clinical programs and plans including proof of concept timing; the advancement of and anticipated clinical development and the conduct of late-stage clinical trials; expected data readouts and approvals; additional planned commercial product launches including tablet formulations; projected regulatory milestones and commercialization of BeiGene’smedicines; the ability of BeiGene’sassets to meaningfully outperform current medicines and address all lines of therap